Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract

Urology

Volumn 66, Issue 6, 2005, Pages 1197-1202

  Tsai, Yuh Shyan ^b   Tzai, Tzong Shin ^a   Chow, Nan Haw ^b   Wu, Chao Liang ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3;

ARTICLE; BLADDER; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE COURSE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY PELVIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; OUTCOMES RESEARCH; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR RECURRENCE; URETER; URINARY TRACT TUMOR; UROGENITAL TRACT TUMOR;

FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; URETERAL NEOPLASMS;

EID: 29144473002     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.06.117     Document Type: Article

References (29)

1. Y.H. Chou, C.H. Huang Unusual clinical presentation of upper urothelial carcinoma in Taiwan Cancer 85 1999 1342 1344
2. M.H. Yang, K.K. Chen, C.C. Yen Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan Urology 59 2002 681 687
3. H. Miyake, I. Hara, S. Arakawa A clinicopathologic study of bladder cancer associated with upper urinary tract cancer BJU Int 85 2000 37 41
4. D.M. Murphy, H. Zincke, W.L. Furlow Management of high-grade transitional cell cancer of the upper urinary tract J Urol 135 1981 25 29
5. N.H. Chow, S.H. Chan, T.S. Tzai Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Clin Cancer Res 7 2001 1957 1962
6. S.F. Shariat, H. Tokunaga, J. Zhou p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer J Clin Oncol 22 2004 1014 1024
7. S.J. Chatterjee, R. Datar, D. Youssefzadeh Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma J Clin Oncol 22 2004 1007 1013
8. R.B. Terrell, J.C. Cheville, W.A. See Histopathologic features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of renal pelvis J Urol 54 1995 1342 1347
9. T. Imai, M. Kimura, M. Takeda Significance of epidermal growth factor receptor and c-ErbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumor recurrence at the urinary bladder Br J Cancer 71 1995 69 72
10. C. Langner, C. Gross, P. Rehak HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma systematic analysis applying tissue microarray technique Urology 65 2005 176 180
11. G.M. Chowdhury, K. Kojima, H.O. Kanayama The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract Cancer 78 1996 827 833
12. K. Inoue, M. Kamada, J.W. Slaton The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter Clin Cancer Res 8 2002 1863 1870
13. D. Yu, M.C. Hung Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 19 2000 6115 6121
14. M. Underwood, J. Bartlett, J. Reeves c-ErbB-2 gene amplification a molecular marker in recurrent bladder tumors? Cancer Res 55 1995 2422 2430
15. D.L. Dankort, W.J. Muller Signal transduction in mammary tumorigenesis a transgenic perspective Oncogene 19 2000 1038 1044
16. J. Cheng, H. Huang, Z.T. Zhang Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth Cancer Res 62 2002 4157 4163
17. Y.S. Tsai, T.S. Tzai, N.H. Chow Prognostic values of p53 and HER-2/neu coexpression in invasive bladder cancer in Taiwan Urol Int 71 2003 262 270
18. INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer Urol Oncol 22 2004 112 118
19. A.D. Thor, D.A. Berry, D.R. Budman erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer J Natl Cancer Inst 90 1998 1346 1360
20. N.H. Chow, H.S. Liu, H.B. Yang Expression patterns of ErbB receptor family in normal urothelium and transitional cell carcinoma an immunohistochemical study Virchows Arch 430 1997 461 466
21. S. Kruger, G. Weitsch, H. Buttner HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic implications Int J Cancer 102 2002 514 518
22. R.E. Jimenez, M. Hussain, F.J. Bianco Jr HER-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder prognostic significance and comparative analysis in primary and metastatic tumors Clin Cancer Res 7 2001 2440 2447
23. Z. Latif, A.D. Watters, I. Dunn HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder Br J Cancer 89 2003 1305 1309
24. L.E. Johannessen, K.E. Haugen, A.C. Ostvold Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms Biochem J 356 2001 87 96
25. V.B. Thogersen, B.S. Sorensen, S.S. Poulsen A subclass of HER1 ligands is prognostic marker for survival in bladder cancer patients Cancer Res 61 2001 6227 6233
26. N.H. Chow, H.S. Liu, E.I. Lee Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer Anticancer Res 17 1997 1293 1296
27. C.H. Kang, T.J. Yu, H.H. Hsieh The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract Cancer 98 2003 1620 1626
28. T. Hisataki, N. Miyao, N. Masumori Risk factors for the development of bladder cancer after upper tract urothelial cancer Urology 55 2000 663 667
29. S. Park, B. Hong, C.S. Kim The impact of tumor location on the prognosis of transitional cell carcinoma of the upper urinary tract J Urol 171 2004 621 625